AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
![]() ![]() At this point, Pfizer/BioNTech were still assessing four different candidates: with a novel design of the trial allowing for the evaluation of the various mRNA candidates simultaneously in order to identify the safest and most efficacious in a greater of number of volunteers, in a manner to facilitate the sharing of data with regulatory authorities in real time. ![]() Here, the Phase 1/2 studies in Germany and the US - designed to determine the safety, immunogenicity and optimal dose level of a vaccine – were already deviating from the norm. Taking the vaccine into the clinicĬlinical trials for the Pfizer/BioNTech vaccine began in May 2020: having brought a potential vaccine using new mRNA tech into the clinic in less than four months. And it notes that the pandemic has accelerated an existing trend towards decentralised and hybrid trials. ![]() It was able to draw on its experience in running trials on the ground during the Ebola pandemic – meaning it was able to adapt to difficult circumstances – but had to scale up this know-how into a global trial working with 150 sites across the US, Europe, South Africa and Latin America.ĭigital innovations – such as remote monitoring – proved their worth in the pandemic and the learnings from COVID-19 trials will be able to help improve future clinical trial processes, says the company. Global contract research organization ICON ran the trial. ![]()
0 Comments
Read More
Leave a Reply. |